Founder Intelligence
Chris Gibson
Advancing technology at Recursion Pharmaceuticals requires rigorous software engineering, disciplined execution, and solving real operational bottlenecks for enterprise users.
- Role
- Founder
- Company
- Recursion Pharmaceuticals
- Country
- United States
- Company founded
- 2013
- Status
- Active
Ecosystem Connection Map
How this founder connects across companies, products, industries, and research on Brel.
Overview
Structured founder intelligence — role, focus, and why this person matters in the AI ecosystem.
Chris Gibson serves as Founder at Recursion Pharmaceuticals in United States. Under this leadership, the organization focuses on developing production-grade artificial intelligence systems, enterprise data pipelines, and scalable machine learning workflows designed to solve critical operational bottlenecks.
Why it matters
Chris Gibson represents executive and engineering leadership in applied artificial intelligence, driving commercialization from foundational research to production software infrastructure.
Career & Timeline
Verified career context from this founder profile.
Role & Leadership at Recursion Pharmaceuticals
As Founder, Chris Gibson steers the strategic execution, technical roadmap, and architectural foundation of Recursion Pharmaceuticals. The executive mandate encompasses aligning model training architectures, operational deployment protocols, and developer-facing APIs with enterprise compliance and performance benchmarks.
Technical Contributions & Industry Context
Chris Gibson's technical stewardship at Recursion Pharmaceuticals addresses core infrastructure challenges in the broader AI ecosystem. By prioritizing verifiable model outputs, robust serving infrastructure, and efficient developer integrations, Recursion Pharmaceuticals provides specialized capabilities in modern intelligent computing.
- Company founded Recursion Pharmaceuticals was founded in 2013 per the company profile source on file. Source
- 2013: Recursion Pharmaceuticals founded in Salt Lake City; Chris Gibson co-founded the company from University of Utah research. Source
- November 20, 2024: Recursion completed its combination with Exscientia; Exscientia became a wholly owned subsidiary. Source
- December 8, 2025: Recursion announced positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, with 43% median polyp burden… Source
- January 1, 2026: Najat Khan, Ph.D., became chief executive officer; Chris Gibson transitioned to chair of the board, per Recursion governance disclosures. Source
Companies
Organizations connected to this founder in the Brel graph.
Products
Products and platforms linked to this founder or their organization.
-
Recursion OS
Explore Recursion OS by Recursion Pharmaceuticals. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,...
View product
Technologies & Expertise
Verified technology terms linked to this founder.
Industries & Use Cases
Sectors and use cases connected to this founder profile.
Industries
Use cases
Latest Developments
Recent milestones from the connected organization.
- Development Source
Related Intelligence
Reports and insights editorially linked to this founder.
-
Report AI in Healthcare: Verified Company Landscape
An evergreen landscape report of 14 verified AI companies in Healthcare covered on Brel Digital, grounded…
-
Report Clinical Documentation: Verified AI Company Landscape
A verified landscape of AI companies on Brel Digital tagged for the Clinical Documentation use case,…
-
Report Generative AI: Verified Company Landscape on Brel
A verified landscape of AI companies on Brel Digital tagged for Generative AI, citing official sources…
-
Report Large Language Models (LLMs): Verified Company Landscape on Brel
A verified landscape of AI companies on Brel Digital tagged for Large Language Models (LLMs), citing…
-
Insight How Brel Maps AI Companies in Medical Imaging
Directory insight linking verified Brel companies tagged for Medical Imaging, with official sources on file.
-
Insight How Brel Maps AI Companies in Ambient Scribing
Directory insight linking verified Brel companies tagged for Ambient Scribing, with official sources on file.
-
Insight How Brel Maps AI Companies in Clinical Documentation
Directory insight linking verified Brel companies tagged for Clinical Documentation, with official sources on file.
-
Insight How Brel Maps AI Companies in Recruiting & Talent
Directory insight linking verified Brel companies tagged for Recruiting & Talent, with official sources on file.
FAQ
Answers restated from verified fields on this profile.
Who is Chris Gibson?
Chris Gibson is a technology leader and entrepreneur currently serving as Founder at Recursion Pharmaceuticals.
What company is Chris Gibson associated with?
Chris Gibson is associated with Recursion Pharmaceuticals, leading product and technical initiatives.
Where is Chris Gibson based?
Chris Gibson is based in United States.
What are Chris Gibson's key contributions to the industry?
Chris Gibson focuses on scalable software architecture, enterprise product development, and applied artificial intelligence leadership at Recursion Pharmaceuticals.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.